Primary |
Psychotic Disorder |
15.5% |
Schizophrenia |
11.9% |
Bipolar Disorder |
8.3% |
Hypothyroidism |
7.1% |
Vitamin Supplementation |
7.1% |
Gastrooesophageal Reflux Disease |
6.0% |
Prostatic Disorder |
6.0% |
Bipolar I Disorder |
4.8% |
Depression |
4.8% |
Hypertension |
4.8% |
Ill-defined Disorder |
4.8% |
Schizoaffective Disorder |
4.8% |
Anxiety |
2.4% |
Diabetes Mellitus |
2.4% |
Hallucination |
2.4% |
Tourette's Disorder |
2.4% |
Agitation |
1.2% |
Dementia Alzheimer's Type |
1.2% |
Electrolyte Imbalance |
1.2% |
Erectile Dysfunction |
1.2% |
|
Weight Increased |
15.6% |
Tardive Dyskinesia |
9.4% |
Thinking Abnormal |
9.4% |
Drug Dose Omission |
6.3% |
Pain |
6.3% |
Psychomotor Hyperactivity |
6.3% |
Tachyphrenia |
6.3% |
Asthenia |
3.1% |
Cardiac Arrest |
3.1% |
Chromaturia |
3.1% |
Condition Aggravated |
3.1% |
Cough |
3.1% |
Disease Recurrence |
3.1% |
Disturbance In Attention |
3.1% |
Drug Hypersensitivity |
3.1% |
Drug Ineffective |
3.1% |
Drug Screen Positive |
3.1% |
Extrapyramidal Disorder |
3.1% |
Fatigue |
3.1% |
Feeling Jittery |
3.1% |
|
Secondary |
Bipolar Disorder |
14.3% |
Schizophrenia |
12.9% |
Depression |
10.0% |
Psychotic Disorder |
8.6% |
Schizoaffective Disorder |
8.6% |
Hypertension |
7.1% |
Mental Disorder |
5.0% |
Hallucination |
3.6% |
Sleep Disorder |
3.6% |
Diabetes Mellitus |
2.9% |
Headache |
2.9% |
Nervousness |
2.9% |
Smoking Cessation Therapy |
2.9% |
Tourette's Disorder |
2.9% |
Gastrooesophageal Reflux Disease |
2.1% |
Hypothyroidism |
2.1% |
Post-traumatic Stress Disorder |
2.1% |
Prostatic Disorder |
2.1% |
Vitamin Supplementation |
2.1% |
Anxiety |
1.4% |
|
Weight Increased |
13.5% |
Psychomotor Hyperactivity |
10.8% |
Therapeutic Response Unexpected |
10.8% |
Schizoaffective Disorder |
8.1% |
Bipolar Disorder |
5.4% |
Drug Hypersensitivity |
5.4% |
Tardive Dyskinesia |
5.4% |
Tremor |
5.4% |
Weight Decreased |
5.4% |
Anxiety |
2.7% |
Blood Glucose Increased |
2.7% |
Blood Pressure Decreased |
2.7% |
Chromaturia |
2.7% |
Cough |
2.7% |
Drug Dose Omission |
2.7% |
Extrapyramidal Disorder |
2.7% |
Fatigue |
2.7% |
Feeling Abnormal |
2.7% |
Generalised Erythema |
2.7% |
Haematuria |
2.7% |
|
Concomitant |
Depression |
19.5% |
Schizophrenia |
17.0% |
Bipolar Disorder |
16.2% |
Anxiety |
9.1% |
Sleep Disorder |
4.5% |
Psychotic Disorder |
3.5% |
Insomnia |
3.2% |
Agitation |
3.0% |
Schizoaffective Disorder |
3.0% |
Mental Disorder |
2.8% |
Pain |
2.8% |
Hypertension |
2.4% |
Smoking Cessation Therapy |
2.0% |
Drug Use For Unknown Indication |
1.8% |
Migraine |
1.8% |
Schizophrenia, Paranoid Type |
1.6% |
Affective Disorder |
1.5% |
Paranoia |
1.5% |
Product Used For Unknown Indication |
1.5% |
Diabetes Mellitus |
1.2% |
|
Type 2 Diabetes Mellitus |
37.1% |
Weight Increased |
11.9% |
Tardive Dyskinesia |
10.0% |
Pancreatitis |
8.2% |
Type 1 Diabetes Mellitus |
5.6% |
Diabetic Coma |
3.0% |
Weight Decreased |
3.0% |
Diabetes Mellitus |
2.8% |
Obesity |
2.6% |
Thyroid Neoplasm |
2.3% |
Diabetic Ketoacidosis |
2.1% |
Hypertension |
2.1% |
Overdose |
1.4% |
Vomiting |
1.4% |
Granulocytopenia |
1.2% |
Neuropathy Peripheral |
1.2% |
Pain |
1.2% |
Vision Blurred |
1.2% |
Blood Triglycerides Increased |
0.9% |
Diabetic Retinopathy |
0.9% |
|
Interacting |
Emotional Disorder |
40.0% |
Mental Disorder |
40.0% |
Smoking Cessation Therapy |
10.0% |
Tobacco User |
6.7% |
Bipolar Disorder |
3.3% |
|
Weight Decreased |
80.0% |
Tension |
20.0% |
|